According to data compiled by ET Now, the performance was driven by robust activity in the Asset Management Company (AMC), Private Wealth Management (PWM), and capital market verticals.

CDSL s Q1 FY26 results reveal a 23.7% YoY decline in consolidated net profit, reaching Rs 102.40 crore, while revenue from operations saw a marginal increase of 0.55% to Rs 258.81 crore. Depository activity revenue increased, but data entry and storage revenue decreased. Total expenses surged by 27.35% YoY to Rs 143.60 crore.

The Nifty index is on a four-week losing streak, influenced by underwhelming Q1 earnings and global trade concerns. Nifty Bank outperformed but faces resistance. Bajaj Finance declined post-earnings. IEX is under pressure due to market coupling news. Healthcare and Pharma sectors show promise. Cipla and Apollo Hospital are likely to do well. The market needs positive global cues for recovery.

The Nifty experienced a week of range-bound trading, closing slightly lower with a 0.53% loss. Facing resistance near the upper edge of a rising channel, the index shows signs of fatigue despite holding above its 20-week moving average. Traders should remain cautious, focusing on stock-specific strategies and protecting gains, as a decisive breakout is needed for a clear directional move.

IDFC First Bank s first quarter of fiscal year 2026 reveals a mixed financial performance. While the profit after tax declined by 32% year-over-year to ₹463 crore, the net interest income experienced a growth of 5.1%, reaching ₹4,933 crore. However, on a quarter-on-quarter basis, the PAT grew significantly by 52.1%.

Nephrocare Health Services, known as NephroPlus, plans to raise funds through an IPO. The IPO includes fresh shares and an offer for sale. Funds will be used for new dialysis clinics and debt repayment. The company is a major dialysis services provider in Asia. It has clinics in multiple countries. ICICI Securities and other firms are managing the IPO.

Sahajanand Medical Technologies (SMT) has filed for an IPO with SEBI to raise funds through an offer-for-sale of 27,644,231 equity shares. Prominent shareholders like Samara Capital and Kotak Pre-IPO Opportunities Fund will be offloading shares. A leading player in India s drug-eluting stent market, SMT boasts a 25% market share. The company s revenue increased to ₹1,024.

Jain Irrigation Systems reported a consolidated net profit of Rs 11.19 crore for the quarter ended June 2025, an 8.5% decrease from the previous year. Despite early monsoon impacting pipe demand, the company saw revenue growth in Micro Irrigation Systems, Tissue Culture, Exports, and Solar Agri Pumps.

Sri Lotus Developers and Realty is launching its IPO next Wednesday, with a grey market premium of Rs 32 over the issue price of Rs 150. The company previously allotted shares at Rs 150 apiece to Bollywood celebrities like Shah Rukh Khan and Amitabh Bachchan.